|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
DAILY VOLUME INDEX
Trading: SELL @ $3
Signal Strength: STRONG
Opthea (ASX:OPT) current price has highlighted the commencement of distribution and the start of bearish trading conditions. Currently, the DVI is -941.
A bearish crossover has been confirmed due the last trading session with is a strong indication of a diretional change. This indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
The daily volume index (DVI) is the amount of individual securities traded in a day on average over a specified period of time. Trading activity relates to the liquidity of a security. When average daily trading volume is high the stock can be easily traded and has high liquidity if trading volume is not very high and the security will tend to be less expensive because people are not as willing to buy it. As a result average daily trading volume can have an effect on the price of the security.
Calculation: Daily Volume Index (DVI):
1) [Close]-[Average price] / [Average price] x [Volume];
PROFILE: Opthea (OPT.AX)
Stock Exchange: ASX
Ticker Codes: | OPT.AX | ASX:OPT |
Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.
|CGC Consolidated Gaming Corporation||3||4.9||7,402,442||-15,533||BEARISH CROSSOVER|
|CIA Champion Iron||2.14||0.9||655,574||-536||BEARISH CROSSOVER|
|AMH Amcil||0.95||0||147,290||-26||BEARISH CROSSOVER|
|TNE Technology One||8.08||0||2,293,266||-915||BEARISH CROSSOVER|
|SHV Select Harvests||6.48||-0.2||569,131||-37||BEARISH CROSSOVER|
|AGL AGL Energy||19.51||-0.4||1,633,130||-768||BEARISH CROSSOVER|
|BLD Boral||4.67||-0.4||4,622,650||-803||BEARISH CROSSOVER|
|FMG Fortescue Metals||10.77||-1||23,866,956||-7,209||BEARISH CROSSOVER|
|SGM Sims||9.58||-1.4||1,053,992||-8||BEARISH CROSSOVER|
|RIO Rio Tinto||90.41||-1.6||1,674,488||-1,652||BEARISH CROSSOVER|